- Home
- News
Novel Glaucoma Risk Locus in African Individuals
August 31, 2026Inas Aboobakar and colleagues including OGI investigators Ayellet Segre and Read More
New Hope for Patients With Dominant RP Due to Rhodopsin Mutations
August 5, 2026The recent publication:A comprehensive map of missense trafficking variants in rhodopsin and their response to pharmacological correction” by Comander lab members Jason Comander, Read More
Hope in Focus Podcast: Understanding Clinical Trials with Dr Jason Comander KLICKAUD
July 21, 2026
Searching For New Genes that Cause Usher syndrome
July 21, 2026Drs. Riccardo Sangermano, Read More
OGI Investigators awarded BrightFocus grants
July 21, 2026Nazlee Zebardast, MD MPH: Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma. Using machine learning to extract richer measures of glaucoma worsening from imaging and... Read More
OGI director Eric Pierce awarded 2026 Llura Liggett Gund Award
May 22, 2026The Foundation Fighting Blindess awarded Eric A. Pierce, MD, PhD the 2026 Llura Liggett Gund Award. The Foundation’s highest honor, the award is presented annually to an individual whose work has... Read More
OGI Director Eric A. Pierce, MD, PhD, received the David F. Weeks Award
April 27, 2026OGI Director Eric A. Pierce, MD, PhD, received the David F. Weeks Award from Research to Prevent Blindness for his pioneering work in inherited retinal disease research and the advancement of genetic therapies... Read More
New publication from Hanmeng Zhang and Pierce lab colleagues.
April 15, 2026We identified oxidative DNA damage as a critical pathogenic mechanism in the Nmnat1-V9M model of inherited retinal disease. Therapeutic targeting of this damage preserves photoreceptors, and may extend to other genetically distinct retinal degenerations with similar mechanism. Read More
OGI members present at The Annual Clinical Genetic Meeting of The American College of Medical Genetics.
March 13, 2026Eric Pierce gave the keynote address – The Evolution of Gene Therapy: Milestones, Challenges, and Future Directions and Read More
Inas Aboobakar Recognized with The David L. Epstein Clinician-Scientist Research Awardat the American glaucoma Society Annual Meeting in February 2026.
March 13, 2026This award from the Chandler Grant Glaucoma Society honors David L. Epstein, MD—one of the most influential leaders in glaucoma and will provide support for ongoing research examining how glaucoma polygenic risk scores interact with social vulnerability indices to identify individuals at greatest disease risk. They identified a large... Read More
A new review from the OGI IPS research lab discusses prime editing of human pluripotent stem cells.
March 13, 2026Marcela Garita Hernandez and colleagues review progress and report on optimization strategies. Read More